Standout Papers

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, ra... 2018 2026 2020 2023 218
  1. Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study (2018)
    Florence Duffaud, Olivier Mir et al. The Lancet Oncology

Immediate Impact

4 by Nobel laureates 10 from Science/Nature 58 standout
Sub-graph 1 of 20

Citing Papers

Aromatic nitrogen scanning by ipso -selective nitrene internalization
2023 StandoutScience
Exploiting senescence for the treatment of cancer
2022 Standout
3 intermediate papers

Works of Nicolás Isambert being referenced

Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analogues
2007
Increase therapy-related leukemia secondary to breast cancer
2000
and 2 more

Author Peers

Author Last Decade Papers Cites
Nicolás Isambert 2966 3185 1343 234 6.6k
Andrew J. Wagner 2997 3273 3271 210 7.9k
Esteban Cvitkovic 5387 2687 2778 214 10.2k
A.T. van Oosterom 3735 2865 1784 176 7.7k
Didier Cupissol 4846 4338 1556 160 8.7k
David C. Harmon 3107 4504 1238 128 7.0k
Steven G. DuBois 1965 2614 2380 275 7.1k
Robert Justice 2481 1657 2757 61 6.3k
Jeffrey A. Gottlieb 2497 1168 898 71 5.0k
Junji Uchida 2142 1824 1252 247 6.2k
Martin E. Blackstein 1944 3860 1019 99 6.2k

All Works

Loading papers...

Rankless by CCL
2026